Catalyst Pharmaceuticals Q1 Adj $0.38 Beats $0.17 Estimate, Sales $98.51M Beat $98.13M Estimate
Catalyst Pharmaceuticals Q1 Adj $0.38 Beats $0.17 Estimate, Sales $98.51M Beat $98.13M Estimate
Catalyst Pharmicals第一季度调整后0.38美元超过预期的0.17美元，销售额为9,851万美元超过9,813万美元的预期
Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.17 by 123.53 percent. This is a 7.32 percent decrease over earnings of $0.41 per share from the same period last year. The company reported quarterly sales of $98.51 million which beat the analyst consensus estimate of $98.13 million by 0.39 percent. This is a 15.40 percent increase over sales of $85.37 million the same period last year.
Catalyst Pharmicals（纳斯达克股票代码：CPRX）公布的季度收益为每股0.38美元，比分析师普遍预期的0.17美元高出123.53％。与去年同期的每股收益0.41美元相比，下降了7.32％。该公司公布的季度销售额为9,851万美元，比分析师普遍预期的9,813万美元高出0.39％。这比去年同期的8,537万美元的销售额增长了15.40％。